November 13, 2025

Why Is the US an ‘Outlier’ in Road Safety?

US traffic fatalities have increased over the past decade despite ongoing safety initiatives.

KFF Health News

November 13, 2025

‘FDA Said Yes, Despite Inconclusive Evidence’

The FDA’s authorization of the Q-Collar is under scrutiny after researchers identified duplicated data, altered study endpoints, and unsubstantiated “brain protection” claims.

Conexiant

November 12, 2025

CDER Taps FDA Veteran as Director 

The HHS and FDA have appointed longtime oncology innovator Richard Pazdur, MD, as director of the Center for Drug Evaluation and Research.

Conexiant

November 12, 2025

Radiation Training Levels May Influence Safety Culture

Researchers examine how radiation knowledge shapes health care safety attitudes.

Conexiant

November 12, 2025

AVM Hemorrhage Risk: Is It Time to Rethink the Data?

Researchers redefine the true hemorrhage risk of unruptured brain arteriovenous malformations.

Conexiant

November 12, 2025

Adverse Pregnancy Outcomes Offer Early Clues to Future AF

Researchers found that adverse pregnancy outcomes increase women’s long-term risk of atrial fibrillation.

Conexiant

November 11, 2025

Testing Metformin’s Reach in PAD

Double-blind trial of 202 patients shows no improvement in 6-minute walk distance at 6 months compared with placebo.

Conexiant

November 10, 2025

FDA Proposes Removal of Box Warnings

The FDA proposed updates to menopausal hormone therapy labeling to reflect current evidence on benefits and risks.

Conexiant

November 10, 2025

Long-Term Safety and Management of Adverse Events Associated With Lorlatinib in ALK-Positive Metastatic NSCLC: A Fictional Case Study

Explore how lorlatinib transformed treatment outcomes for a patient with ALK-positive metastatic NSCLC while highlighting the importance of effective management strategies.

JADPRO